All data are based on the daily closing price as of March 20, 2026
l

L&C Bio

290650.KQ
50.53 USD
0.16
+0.32%

Overview

Last close
50.53 usd
Market cap
1.24B usd
52 week high
81.75 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
23.0119
Price/Book Value
7.1851
Enterprise Value
1.26B usd
EV/Revenue
23.6693
EV/EBITDA
12.9708

Key financials

Revenue TTM
50.47M usd
Gross Profit TTM
24.80M usd
EBITDA TTM
3.77M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
355.50M usd
Net debt
45.16M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top